Advertisement

Topics

Sartorius Corporation Company Profile

22:25 EDT 22nd March 2019 | BioPortfolio

Sartoris ranks among the international market and technology leaders in the fields of mechatronics, biotechnology and environmental technology. Sartorius is now a group of DIN ISO 9001 certified companies with a long tradition of excellence and innovative strength. In mechatronics, the interdisciplinary combination of mechanical and electronic engineering and information technology, Sartorius is increasingly focusing on the customer’s chain of processes with its broad range of products for laboratory and industrial weighing, including electrochemistry.

Location

131 Heartland Boulevard
Edgewood
NY
11717
United States of America

Contact

Phone: 516 254 4249
Fax: 516 254 4253
Email: info.investor@sartorius.com


News Articles [168 Associated News Articles listed on BioPortfolio]

Sartorius continues to grow by double digits

Sartorius continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kr...

Sartorius Stedim Biotech und Lonza modifizieren Zusammenarbeit beim Zellkulturmedien-Geschäft

Sartorius Stedim Biotech bietet weiterhin Lonza-Zellkulturmedien und -Pufferlösungen an, aber nicht exklusiv Sartorius Stedim Biotech wird Lonzas Vorzugslieferant für Bioprozess-Equipment und Verb.....

Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca

Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Sartorius Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist for ce...

Lonza, Sartorius Modify Cell Culture Supply Pact

Sartorius will continue to offer Lonza products under a non-exclusive agreement

Abzena Selects Sartorius as U.S. Equipment Supplier

Sartorius Stedim will equip Abzena's CDMO facilities in Bristol, PA and San Diego, CA with end-to-end process solutions

Sartorius Stedim Biotech SA: Information on Document Availability

Dow Jones received a payment from EQS/DGAP to publish this press release. Sartorius Stedim Biotech SA Sartorius Stedim Biotech SA: Information on Document Availability 19-Feb-2019 / 07:34 CET/CEST...

Sartorius Stedim BioOutsource adds NBD product characterization to service lineup

Sartorius Stedim Biotechâs contract testing subsidiary is adding services offer increased support to clients developing new biological entities.

Sartorius Stedim BioOutsource adds NBE product characterization to service lineup

Sartorius Stedim Biotechâs contract testing subsidiary is adding services offer increased support to clients developing new biological entities.

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study

Background: Treatment options are limited for patients with hidradenitis suppurativa (HS). Apremilast, an oral phosphodiesterase 4 inhibitor, may offer an attractive therapeutic option for patients wi...

Mast cells in hidradenitis suppurativa: a clinicopathological study.

Mast cells (MC) have been observed in hidradenitis suppurativa (HS) lesions. Their potential role in the pathogenesis of HS is unknown. The aim of this study was to assess the number and distribution ...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Postoperative Management of Groin Flaps for Vascular Coverage

This is a randomized controlled trial designed to analyze the impact of bedrest duration on return to functional independence at discharge following sartorius flap for coverage of vascular...

Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa

The trial enrolls patients with moderate to severe Hidradenitis Suppurativa (HS). The primary goal of the trial is to evaluate the safety and tolerability of IFX-1 administered over 8 week...

Femoral Nerve Block: Anatomical Insertion Point - A Prospective Randomised Double-Blind Controlled Trial

Nerve blocks are an effective way to control pain after surgery. There are two major nerves that provide sensation to the knee: the femoral nerve provides sensation to the front of the kne...

Companies [188 Associated Companies listed on BioPortfolio]

Sartorius Corporation

Sartoris ranks among the international market and technology leaders in the fields of mechatronics, biotechnology and environmental technology. Sartorius is now a group of DIN ISO 9001 certified compa...

Sartorius

The Sartorius Group is a leading international pharmaceutical and laboratory equipment provider with two divisions: Bioprocess Solutions and Lab Products & Services. Bioprocess So...

Sartorius AG

The Sartorius Group is an internationally leading laboratory and process technology supplier covering the segments of biotechnology and mechatronics. In 2005, the technology group earned sales revenue...

Sartorius Electronics

Nil

Sartorius Stedim Biotech

21.1

More Information about "Sartorius Corporation" on BioPortfolio

We have published hundreds of Sartorius Corporation news stories on BioPortfolio along with dozens of Sartorius Corporation Clinical Trials and PubMed Articles about Sartorius Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sartorius Corporation Companies in our database. You can also find out about relevant Sartorius Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record